Financials

  • Market Capitalization 1.05 B
  • Employee 121
  • Founded 2013
  • CEO N/A
  • Website www.solidbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00JN4FXG8
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.31
ratio cours/chiffre d'affaires
-165.87

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2414
SVRA
Savara, Inc. - Common Stock
5.26 USD-4.19%-6.07%-3.31%+60.37%1.08 B USD
2424
AVTX
Avalo Therapeutics, Inc. - Common Stock
19.59 USD-2.29%-1.36%+7.28%+111.56%1.05 B USD
2441
LXRX
Lexicon Pharmaceuticals, Inc. - Common Stock
2.29 USD-1.29%-1.29%-0.43%+104.46%1.02 B USD
2452
ABUS
Arbutus Biopharma Corporation - Common Stock
5.07 USD-1.93%-2.12%+16.82%+37.40%1.00 B USD

Nouvelles